Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
Kenichi Harano, Karen Allan, Alessandra Bologna, Sara Uggeri et al.
Citations
3 citations
Journal
Journal of Gynecologic Oncology
Topics
Endometrial and Cervical Cancer Treatments
Field-Weighted Citation Impact (FWCI)
6.17
article
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
Kenichi Harano, Karen Allan, Alessandra Bologna, Sara Uggeri, Janine Lombard, Roldano Fossati, Francesca Galli, Satoshi Nakagawa, Florian Heitz, Yoland Antill, B. Pardo, Shin Nishio, Luís Manso, Kazuhiro Takehara, Angiolo Gadducci, Maria-Pilar Barretina-Ginesta, Antonio Ardizzoia, Elena Biagioli, Cláudia Casanova, Chyong‐Huey Lai, Manuela Rabaglio, Yeh Chen Lee, Andrés Redondo, V Kolovetsiou-Kreiner, Innocenza Palaia, Edi Editta Baldini, Nicoletta Colombo, Chulmin Lee, E. Hudson, E. Au
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Gynecologic OncologyVol. 36(4)
Institutions
Kurume University (JP), University of Pisa (IT), IMT School for Advanced Studies Lucca (IT), The University of Sydney (AU), University of Milan (IT), Mario Negri Institute for Pharmacological Research (IT), Medical University of Graz (AT), Hospital Universitario La Paz (ES), University Hospital of Bern (CH), Chang Gung Memorial Hospital (TW), Research Institute Hospital 12 de Octubre (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Dongguk University Ilsan Hospital (KR), Institut Català d'Oncologia (ES), Alessandro Manzoni Hospital (IT), Peninsula Health (AU), National Health Insurance Service Ilsan Hospital (KR), Shikoku Cancer Center (JP), Duran i Reynals Hospital (ES), National Cancer Center Hospital East (JP), Kliniken Essen-Mitte (DE), Calvary Mater Newcastle Hospital (AU), Velindre Cancer Centre (GB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), National Health and Medical Research Council (AU), Monash University (AU), European Institute of Oncology (IT), University of Glasgow (GB), Sapienza University of Rome (IT), The University of Osaka (JP)